(Q40903132)

24 September 2017

1 reference

title

Universal community carrier screening for cystic fibrosis? (English)

1 reference

24 September 2017

0 references

Williamson R

1

1 reference

PubMed ID

8485573

24 September 2017

language of work or name

English

0 references

publication date

1 March 1993

1 reference

24 September 2017

1 reference

24 September 2017

3

1 reference

24 September 2017

3

1 reference

24 September 2017

195-201

1 reference

https://scigraph.springernature.com/pub.10.1038/ng0393-195

24 September 2017

0 references

cites work

Psychological and social consequences of community carrier screening programme for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

The spectrum of cystic fibrosis mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

Guthrie cards for detection of point mutations in phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

DNA typing from single hairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

Couple screening for cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

Two steps closer to gene therapy for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

FIRST-TRIMESTER PRENATAL DIAGNOSIS OF CYSTIC FIBROSIS WITH LINKED DNA PROBES

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

Prenatal screening for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Localization of cystic fibrosis locus to human chromosome 7cen–q22

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker.

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

A closely linked genetic marker for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Prenatal diagnosis of cystic fibrosis by DNA amplification for detection of KM-19 polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Identification of the cystic fibrosis gene: genetic analysis

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Identification of the cystic fibrosis gene: chromosome walking and jumping

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Services for thalassaemia as a model for cost-benefit analysis of genetics services

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

The Tiresias complex: Huntington's disease as a paradigm of testing for late-onset disorders

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Detection of over 98% cystic fibrosis mutations in a Celtic population

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Cystic fibrosis mutations in French Canadians: three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Effect of introducing prenatal diagnosis on the reproductive behaviour of families at risk for cystic fibrosis. A cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Effect of introducing antenatal diagnosis on reproductive behaviour of families at risk for thalassaemia major

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Community attitudes to cystic fibrosis carrier testing in England: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Screening for carriers of cystic fibrosis through primary health care services

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Simple non-invasive method to obtain DNA for gene analysis

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Guthrie spots for DNA-based carrier testing in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Rapid preparation of genomic DNA from dried blood and saliva spots for polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Cystic fibrosis carrier screening at first diagnosis of pregnancy in general practice

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Screening for cystic fibrosis carriers

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Detection of delta F508 deletion by amplification refractory mutation system

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

A pooling strategy for heterozygote screening of the delta F508 cystic fibrosis mutation.

1 reference

https://api.crossref.org/works/10.1038%2FNG0393-195

7 January 2021

Identifiers

DOI

10.1038/NG0393-195

1 reference

PubMed ID

8485573

Dimensions Publication ID

24 September 2017

0 references

1 reference

PubMed ID

8485573